Page 9 - தொடர்பாக முன்னோக்கி பார்க்கிறது அறிக்கைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Operator Good day and thank you for standing by. Welcome to the Vanda Pharmaceuticals Inc Second Quarter 2021 Earnings Conference Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Kevin Moran, Vanda s Chief Financial Officer. Please go ahead. Please go ahead. Senior Vice President, Chief Financial Officer and Treasurer Thank you, Joel. Good afternoon and thank you for joining us to discuss Vanda Pharmaceuticals Second Quarter 2021 performance. Our second quarter 2021 results released this afternoon and are available on the SEC s EDGAR system and on our website www.vandapharma.com. In addition, we are providing live and archived versions of this conference call on our website. Joining me on today s call is Dr. Mihael Polymeropoulos, our President, Chief Executive office and Chairman of the Board. Following my introductory remarks, Mihael will update you on our ongoing activities. I will then comment on our financial results before o

United statesOlivia brayerMihaelh polymeropoulosMihael polymeropoulosKevin moranVanda pharmaceuticals incAmerica equity researchVanda pharmaceuticals inc second quarterOlivia brayer bankVanda pharmaceuticals second quarterChief financialVice presidentChief financial officerChief executiveRegarding forward looking statementsRisk factors